CME Group Inc (CME) is slightly overvalued and MSCI Inc (MSCI) is overvalued.
Both trade above our estimate of their intrinsic value. CME is the closer of the two: -15%, against -53% for MSCI.
Values as of the 22 Sept 2026 close.
Discounting its cash flows at 7.3% (average of 3 methods) values the shares at $232.06; the price of $267.21 is 15% above that value, and 82% of that value comes from beyond year five.
Leak Score 61/100 on 8 of 12 signals
Discounting its cash flows at 10.1% (average of 3 methods) values the shares at $357.60; the price of $548.88 is 53% above that value, and 73% of that value comes from beyond year five.
Leak Score 72/100 on 8 of 12 signals
| Metric | CME | MSCI |
|---|---|---|
| Verdict | Slightly overvalued | Overvalued |
| Price | $267.21 | $548.88 |
| Intrinsic value | $232.06 | $357.60 |
| Margin of safety | -15% | -53% |
| Leak Score | 61/100 (8/12) | 72/100 (8/12) |
| Market cap | $96.1B | $39.9B |
| Revenue growth, 5 years | 6.0% | 13.1% |
| Operating margin | 65.1% | 55.7% |
| Net margin | 63.1% | 40.7% |
| Return on equity | 15.8% | — |
| Debt to equity | 0.15 | — |
| P/E | 22.7x | 30.0x |
| Forward P/E | 20.7x | 24.4x |
| P/B | 3.6x | — |
| Dividend yield | 4.3% | 1.5% |